Jean-Francois Martini
Senior Director, BioPharma Translational Strategy & Applications Guardant Health
Seminars
Tuesday 31st March 2026
Improving Drug Development Programs with Novel Epigenomic Insights
1:00 pm
- A deep dive into epigenomic biomarkers within the precision oncology toolkit, and how methylation-based signatures reveal tumour biology beyond genomics
- An overview of emerging data demonstrating where epigenomic biomarkers deliver the greatest impact for patient stratification and trial enrichment
- A discussion of Guardant Health’s expanding global testing capabilities and their role in advancing epigenomics in clinical care
